Concord Medical Services (NYSE:CCM) Coverage Initiated at StockNews.com
by Jessica Moore · The Cerbat GemAnalysts at StockNews.com began coverage on shares of Concord Medical Services (NYSE:CCM – Get Free Report) in a research report issued to clients and investors on Saturday. The brokerage set a “sell” rating on the stock.
Concord Medical Services Price Performance
NYSE CCM opened at $5.70 on Friday. The company has a debt-to-equity ratio of 1.14, a current ratio of 0.32 and a quick ratio of 0.30. Concord Medical Services has a fifty-two week low of $3.82 and a fifty-two week high of $26.70. The business has a fifty day moving average of $6.91 and a 200-day moving average of $6.71.
Concord Medical Services Company Profile
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.
Recommended Stories
- Five stocks we like better than Concord Medical Services
- How to Calculate Options Profits
- 3 Stocks That Could Rise on European Bank Interest Rate Cuts
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- Most Volatile Stocks, What Investors Need to Know
- MarketBeat Week in Review – 9/16 – 9/20